Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asym./Biol. Unit
(-)Asym./Biol. Unit - sites
collapse expand < >
Image Asym./Biol. Unit
Asym./Biol. Unit  (Jmol Viewer)
Image Asym./Biol. Unit - sites
Asym./Biol. Unit - sites  (Jmol Viewer)

(-) Description

Title :  STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS
 
Authors :  S. Kleanthous, A. D. Borthwick, D. Brown, C. L. Burns-Kurtis, M. Campbe L. Chaudry, C. Chan, M. Clarte, M. A. Convery, J. D. Harling, E. Hortens W. R. Irving, S. Irvine, A. J. Pateman, A. Patikis, I. L. Pinto, D. R. Pol T. J. Roethka, S. Senger, G. P. Shah, G. J. Stelman, J. R. Toomey, N. S. Wa C. Whittaker, P. Zhou, R. J. Young
Date :  16 Nov 09  (Deposition) - 01 Dec 10  (Release) - 01 Dec 10  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  2.38
Chains :  Asym./Biol. Unit :  A,B
Keywords :  Blood Clotting, Serine Protease, Egf-Like Domain, Blood Coagulation, Hydrolase, Hydroxylation, Zymogen (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  S. Kleanthous, A. D. Borthwick, D. Brown, C. L. Burns-Kurtis, M. Campbell, L. Chaudry, C. Chan, M. Clarte, M. A. Convery, J. D. Harling, E. Hortense, W. R. Irving, S. Irvine, A. J. Pateman, A. Patikis, I. L. Pinto, D. R. Pollard, T. J. Roethka, S. Senger, G. P. Shah, G. J. Stelman, J. R. Toomey, N. S. Watson, C. Whittaker, P. Zhou, R. J. Young
Structure And Property Based Design Of Factor Xa Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
Bioorg. Med. Chem. Lett. V. 20 618 2010
PubMed-ID: 20006499  |  Reference-DOI: 10.1016/J.BMCL.2009.11.077

(-) Compounds

Molecule 1 - ACTIVATED FACTOR XA HEAVY CHAIN
    ChainsA
    EC Number3.4.21.6
    FragmentACTIVATED DESGLA, RESIDUES 235-488
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    Other DetailsDISULPHIDE LINKED TO OTHER CHAIN
    Other Details - SourcePURCHASED FROM ENZYME RESEARCH LABS, ISOLATED FROM HUMAN BLOOD
    TissueBLOOD
 
Molecule 2 - FACTOR X LIGHT CHAIN
    ChainsB
    EC Number3.4.21.6
    FragmentACTIVATED DESGLA, RESIDUES 46-179
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    Other DetailsDISULPHIDE LINKED TO OTHER CHAIN
    Other Details - SourcePURCHASED FROM ENZYME RESEARCH LABS, ISOLATED FROM HUMAN BLOOD
    TissueBLOOD

 Structural Features

(-) Chains, Units

  12
Asymmetric/Biological Unit AB

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (1, 1)

Asymmetric/Biological Unit (1, 1)
No.NameCountTypeFull Name
18981Ligand/Ion(E)-2-(5-CHLOROTHIOPHEN-2-YL)-N-[(3S)-1-{4-[(1S)-1-(DIMETHYLAMINO)ETHYL]-2-FLUOROPHENYL}-2-OXOPYRROLIDIN-3-YL]ETHENESULFONAMIDE

(-) Sites  (1, 1)

Asymmetric Unit (1, 1)
No.NameEvidenceResiduesDescription
1AC1SOFTWARELYS A:96 , GLU A:97 , THR A:98 , TYR A:99 , ASP A:189 , ALA A:190 , GLN A:192 , VAL A:213 , TRP A:215 , GLY A:216 , GLY A:219 , CYS A:220 , GLY A:226 , ILE A:227 , TYR A:228 , HOH A:2064BINDING SITE FOR RESIDUE 898 A1244

(-) SS Bonds  (8, 8)

Asymmetric/Biological Unit
No.Residues
1A:22 -A:27
2A:42 -A:58
3A:122 -B:44
4A:168 -A:182
5A:191 -A:220
6B:1 -B:12
7B:8 -B:21
8B:23 -B:36

(-) Cis Peptide Bonds  (0, 0)

(no "Cis Peptide Bond" information available for 2WYJ)

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (23, 23)

Asymmetric/Biological Unit (23, 23)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_065434E142KFA10_HUMANUnclassified (FA10D)61753266BE14K
02UniProtVAR_065435C149YFA10_HUMANDisease (FA10D)  ---BC21Y
03UniProtVAR_065436C151YFA10_HUMANDisease (FA10D)  ---BC23Y
04UniProtVAR_020176A152TFA10_HUMANPolymorphism3211772BA24T
05UniProtVAR_075213G262DFA10_HUMANUnclassified (FA10D)  ---AG43D
06UniProtVAR_065437G289RFA10_HUMANDisease (FA10D)121964946AG69R
07UniProtVAR_065438E304KFA10_HUMANDisease (FA10D)747292771AE84K
08UniProtVAR_065439D322NFA10_HUMANDisease (FA10D)121964942AD102N
09UniProtVAR_065440R327WFA10_HUMANDisease (FA10D)770119164AR107W
10UniProtVAR_065441V338MFA10_HUMANDisease (FA10D)121964947AV118M
11UniProtVAR_065442E350KFA10_HUMANDisease (FA10D)372309538AE129K
12UniProtVAR_065443T358MFA10_HUMANDisease (FA10D)768222784AT135M
13UniProtVAR_065444G363SFA10_HUMANDisease (FA10D)  ---AG140S
14UniProtVAR_065445R366CFA10_HUMANDisease (FA10D)104894392AR143C
15UniProtVAR_065446S374PFA10_HUMANDisease (FA10D)121964941AS152P
16UniProtVAR_072751V382AFA10_HUMANDisease (FA10D)  ---AV160A
17UniProtVAR_065447P383SFA10_HUMANDisease (FA10D)121964940AP161S
18UniProtVAR_065448C390FFA10_HUMANDisease (FA10D)199778916AC168F
19UniProtVAR_065449C404RFA10_HUMANDisease (FA10D)  ---AC182R
20UniProtVAR_065450G406SFA10_HUMANDisease (FA10D)376163818AG184S
21UniProtVAR_065451G420RFA10_HUMANDisease (FA10D)750759634AG196R
22UniProtVAR_072752G421DFA10_HUMANDisease (FA10D)758726161AG197D
23UniProtVAR_065452K448NFA10_HUMANDisease (FA10D)  ---AK224N

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (4, 4)

Asymmetric/Biological Unit (4, 4)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1EGF_2PS01186 EGF-like domain signature 2.FA10_HUMAN110-121
149-164
  1-
B:21-36
2TRYPSIN_DOMPS50240 Serine proteases, trypsin domain profile.FA10_HUMAN235-467  1A:16-243
3TRYPSIN_HISPS00134 Serine proteases, trypsin family, histidine active site.FA10_HUMAN272-277  1A:53-58
4TRYPSIN_SERPS00135 Serine proteases, trypsin family, serine active site.FA10_HUMAN413-424  1A:189-200

(-) Exons   (4, 5)

Asymmetric/Biological Unit (4, 5)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1bENST000003755591bENSE00001885902chr13:113777132-113777239108FA10_HUMAN1-24240--
1.2ENST000003755592ENSE00001757906chr13:113783766-113783926161FA10_HUMAN24-77540--
1.4ENST000003755594ENSE00001666002chr13:113792771-11379279525FA10_HUMAN78-8690--
1.5ENST000003755595ENSE00001614193chr13:113793671-113793784114FA10_HUMAN86-124390--
1.6cENST000003755596cENSE00000862532chr13:113795233-113795364132FA10_HUMAN124-168451-
B:-2-40
-
43
1.7aENST000003755597aENSE00001710199chr13:113798165-113798409245FA10_HUMAN168-249822A:16-30
B:40-49
15
10
1.8eENST000003755598eENSE00000862534chr13:113801693-113801810118FA10_HUMAN250-289401A:31-69
-
40
-
1.9cENST000003755599cENSE00001616173chr13:113803230-113803843614FA10_HUMAN289-4882001A:69-243 (gaps)
-
181
-

(-) Sequences/Alignments

Asymmetric/Biological Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:230
 aligned with FA10_HUMAN | P00742 from UniProtKB/Swiss-Prot  Length:488

    Alignment length:233
                                   244       254       264       274       284       294       304       314       324       334       344       354       364       374       384       394       404       414       424       434       444       454       464   
          FA10_HUMAN    235 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMK  467
               SCOP domains d2wyja_ A: automated matches                                                                                                                                                                                                              SCOP domains
               CATH domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ....ee........eeeeee....eeeeeee....eeeehhhhhhh...eeeee........---.eeeeeeeeee.............eeeee................hhhhhhhhh....eeeeee..............eeeeee..hhhhhhhhh.......eeee................eeeeee..eeeeeeeeee..........eeeee...hhhhhhhhhh Sec.struct. author
                 SAPs(SNPs) ---------------------------D--------------------------R--------------K-----------------N----W----------M-----------K-------M----S--C-------P-------AS------F-------------R-S-------------RD--------------------------N------------------- SAPs(SNPs)
                PROSITE (1) TRYPSIN_DOM  PDB: A:16-243 UniProt: 235-467                                                                                                                                                                                               PROSITE (1)
                PROSITE (2) -------------------------------------TRYPSI---------------------------------------------------------------------------------------------------------------------------------------TRYPSIN_SER ------------------------------------------- PROSITE (2)
           Transcript 1 (1) ---------------Exon 1.8e  PDB: A:31-69 UniProt: 250-289---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript 1 (1)
           Transcript 1 (2) Exon 1.7a      ---------------------------------------Exon 1.9c  PDB: A:69-243 (gaps) UniProt: 289-488 [INCOMPLETE]                                                                                                                       Transcript 1 (2)
                2wyj A   16 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQE---EAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMK  243
                                    25        35        45        55      | 64        74 |   |  84        94       104       114      124A       131       141   ||  152       162       172       182   ||  190       200       210      |221  |    230       240   
                                                                        61A             76  80                                        124A    131A|            145|                                   185A|                             217| 223A                    
                                                                                                                                               131B             147                                    185B                              219                         

Chain B from PDB  Type:PROTEIN  Length:52
 aligned with FA10_HUMAN | P00742 from UniProtKB/Swiss-Prot  Length:488

    Alignment length:52
                                   135       145       155       165       175  
          FA10_HUMAN    126 RKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTL  177
               SCOP domains d2wyjb_ B: Factor X, N-terminal module               SCOP domains
               CATH domains ---------------------------------------------------- CATH domains
               Pfam domains ---------------------------------------------------- Pfam domains
         Sec.struct. author .hhhhhhhhhh..eeeee..eeeee....eee......eee........... Sec.struct. author
                 SAPs(SNPs) ----------------K------Y-YT------------------------- SAPs(SNPs)
                PROSITE (1) -----------------------EGF_2           ------------- PROSITE (1)
                PROSITE (2) ---------------------------------------------------- PROSITE (2)
           Transcript 1 (1) Exon 1.6c  PDB: B:-2-40 UniProt: 124-168   --------- Transcript 1 (1)
           Transcript 1 (2) ------------------------------------------Exon 1.7a  Transcript 1 (2)
                2wyj B   -2 RKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTL   49
                                     7        17        27        37        47  

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (2, 2)

Asymmetric/Biological Unit

(-) CATH Domains  (0, 0)

(no "CATH Domain" information available for 2WYJ)

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 2WYJ)

(-) Gene Ontology  (22, 22)

Asymmetric/Biological Unit(hide GO term definitions)
Chain A,B   (FA10_HUMAN | P00742)
molecular function
    GO:0005509    calcium ion binding    Interacting selectively and non-covalently with calcium ions (Ca2+).
    GO:0016787    hydrolase activity    Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
    GO:0008233    peptidase activity    Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.
    GO:0005543    phospholipid binding    Interacting selectively and non-covalently with phospholipids, a class of lipids containing phosphoric acid as a mono- or diester.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0004252    serine-type endopeptidase activity    Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
    GO:0008236    serine-type peptidase activity    Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
biological process
    GO:0006888    ER to Golgi vesicle-mediated transport    The directed movement of substances from the endoplasmic reticulum (ER) to the Golgi, mediated by COP II vesicles. Small COP II coated vesicles form from the ER and then fuse directly with the cis-Golgi. Larger structures are transported along microtubules to the cis-Golgi.
    GO:0007596    blood coagulation    The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
    GO:0007598    blood coagulation, extrinsic pathway    A protein activation cascade that contributes to blood coagulation and consists of the self-limited process linking exposure and activation of tissue factor to the activation of clotting factor X.
    GO:0007597    blood coagulation, intrinsic pathway    A protein activation cascade that contributes to blood coagulation and consists of the interactions among high molecular weight kininogen, prekallikrein, and factor XII that lead to the activation of clotting factor X.
    GO:0007599    hemostasis    The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.
    GO:0017187    peptidyl-glutamic acid carboxylation    The gamma-carboxylation of peptidyl-glutamic acid; catalyzed by the vitamin K dependent gamma-glutamyl carboxylase.
    GO:0030335    positive regulation of cell migration    Any process that activates or increases the frequency, rate or extent of cell migration.
    GO:0051897    positive regulation of protein kinase B signaling    Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
    GO:0006508    proteolysis    The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
    GO:0006465    signal peptide processing    The proteolytic removal of a signal peptide from a protein during or after transport to a specific location in the cell.
cellular component
    GO:0005796    Golgi lumen    The volume enclosed by the membranes of any cisterna or subcompartment of the Golgi apparatus, including the cis- and trans-Golgi networks.
    GO:0005788    endoplasmic reticulum lumen    The volume enclosed by the membranes of the endoplasmic reticulum.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0031233    intrinsic component of external side of plasma membrane    The component of a plasma membrane consisting of gene products and protein complexes that penetrate the external side of the plasma membrane only, either directly or via some covalently attached hydrophobic anchor.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

 Visualization

(-) Interactive Views

Asymmetric/Biological Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    898  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
(no "Cis Peptide Bonds" information available for 2wyj)
 

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  2wyj
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  FA10_HUMAN | P00742
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  3.4.21.6
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  227600
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  FA10_HUMAN | P00742
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        FA10_HUMAN | P007421c5m 1ezq 1f0r 1f0s 1fax 1fjs 1fxy 1g2l 1g2m 1hcg 1ioe 1iqe 1iqf 1iqg 1iqh 1iqi 1iqj 1iqk 1iql 1iqm 1iqn 1ksn 1lpg 1lpk 1lpz 1lqd 1mq5 1mq6 1msx 1nfu 1nfw 1nfx 1nfy 1nl8 1p0s 1v3x 1wu1 1xka 1xkb 1z6e 2bmg 2boh 2bok 2bq6 2bq7 2bqw 2cji 2d1j 2ei6 2ei7 2ei8 2fzz 2g00 2gd4 2h9e 2j2u 2j34 2j38 2j4i 2j94 2j95 2jkh 2p16 2p3f 2p3t 2p3u 2p93 2p94 2p95 2phb 2pr3 2q1j 2ra0 2uwl 2uwo 2uwp 2vh0 2vh6 2vvc 2vvu 2vvv 2vwl 2vwm 2vwn 2vwo 2w26 2w3i 2w3k 2wyg 2xbv 2xbw 2xbx 2xby 2xc0 2xc4 2xc5 2y5f 2y5g 2y5h 2y7x 2y7z 2y80 2y81 2y82 3cen 3cs7 3ens 3ffg 3hpt 3iit 3k9x 3kl6 3kqb 3kqc 3kqd 3kqe 3liw 3m36 3m37 3q3k 3sw2 3tk5 3tk6 4a7i 4bti 4btt 4btu 4y6d 4y71 4y76 4y79 4y7a 4y7b 4zh8 4zha 5jqy 5jtc 5jz8 5jzu 5k0h

(-) Related Entries Specified in the PDB File

1c5m STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
1ezq CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515
1f0r CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815
1f0s CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707
1fax COAGULATION FACTOR XA INHIBITOR COMPLEX
1fjs CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA
1g2l FACTOR XA INHIBITOR COMPLEX
1g2m FACTOR XA INHIBITOR COMPLEX
1hcg BLOOD COAGULATION FACTOR XA
1ioe HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532
1iqe HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590
1iqf HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165
1iqg HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159
1iqh HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143
1iqi HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125
1iqj HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124
1iqk HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113
1iql HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476
1iqm HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471
1iqn HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192
1ksn CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673
1kye FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE
1lpg CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79.
1lpk CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125.
1lpz CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41.
1lqd CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45.
1mq5 CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA
1mq6 CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA
1msx HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS.
1nfu CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747
1nfw CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685
1nfx CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944
1nfy CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095
1nl8 THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX
1p0s CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R
1v3x FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE
1wu1 FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE
1xka FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID
1xkb FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID
1z6e CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN
2bmg CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50
2boh CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1
2bok FACTOR XA - CATION
2bq6 CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21
2bq7 CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43
2bqw CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45
2cji CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2fzz FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE
2g00 FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1- YL)BENZAMIDE
2gd4 CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX
2j2u CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2j34 CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2j38 CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2j4i CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2j94 CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2j95 CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2jkh FACTOR XA - CATION INHIBITOR COMPLEX
2uwl SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA
2uwo SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA
2uwp FACTOR XA INHIBITOR COMPLEX
2vh0 STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS
2vh6 STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS
2vvc AMINOPYRROLIDINE FACTOR XA INHIBITOR
2vvu AMINOPYRROLIDINE FACTOR XA INHIBITOR
2vvv AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR
2vwl AMINOPYRROLIDINE FACTOR XA INHIBITOR
2vwm AMINOPYRROLIDINE FACTOR XA INHIBITOR
2vwn AMINOPYRROLIDINE FACTOR XA INHIBITOR
2vwo AMINOPYRROLIDINE FACTOR XA INHIBITOR
2w26 FATOR XA IN COMPLEX WITH BAY59-7939
2w3i CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 2
2w3k CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 1
2wyg STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS